Late stage CKD therapeutics market seen reaching $25.20 billion by 2032

ResearchAndMarkets.com says the global market was valued at $13.02 billion in 2025 and is forecast to grow at a 9.88% CAGR as integrated care models, newer therapies and reimbursement dynamics reshape adoption.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.